Právní předpis byl sestaven k datu 25.07.2019.
Zobrazené znění právního předpisu je účinné od 04.01.2018 do 25.07.2019.
80
XXXXXXX
Xxxxxxxxxxxx xxxxxxxxxxxx věcí,
kterým xx xxxx x xxxxxxxx sdělení Xxxxxxxxxxxx xxxxxxxxxxxx xxxx x. 58/2007 Xx. x. x. x č. 46/2008 Xx. x. x.
Xxxxxxxxxxxx xxxxxxxxxxxx věcí xxxxxxx, xx xxx 28. xxxxxxxxx 2016 xxxx xxxxxxxxx xxxxxxxxxx XXXXXX xxxxxxxx xxxxxxxxx xxxxxx xxxxx Xxxxxxx X (Xxxxxx xxxxxxxxxx xxxxx x metod xxxxxxx pro xxx 2017 - Mezinárodní xxxxxxxx) Xxxxxxxxxxx xxxxxx xxxxx dopingu ve xxxxxx1).
X xxxxx zněním Xxxxxxx X xxxxxxxx xxxxxxx Xxxxxxxxx Xxxxx xxxxxxxxx x xxxxxxxxx xxxxxxxxx xxxxxxxx xxxxxxx x xxxxxxx xxxx Xxxxxxx X Xxxxxx xxxxxxxxxx.
Xxxx xxxxx Xxxxxxx X xxxxxxxxx x xxxxxxxx x xxxxxxx x článkem 34 xxxx. 3 Xxxxxx dne 1. xxxxx 2017 x xxx Xxxxxx xxxxxxxxx vstoupilo x xxxxxxxx xxx 30. xxxxx 2017.
Dnem vstupu xxxxxx xxxxx Přílohy X x xxxxxxxx xxxxxxxx xxxxxx xxxxx Xxxxxxx X xxxxxx xx 1. ledna 2016, xxxxxxxxx xxx č. 26/2017 Sb. m. s.
Xxxxxxxx xxxxx Přílohy X a xxxx xxxxxxx xx českého xxxxxx se xxxxxxxxx xxxxxxxx.
XXXXXXX ANTIDOPINGOVÝ KODEX
SEZNAM XXXXXXXXXX LÁTEK X XXXXX XXXXXXX XXX XXX 2017
XXXXXXXXXXX STANDARD
Oficiální xxxx Xxxxxxx xxxx xxxxxxxxx WADA a xxxx publikován x xxxxxxxxxx x francouzštině.
V xxxxxxx xxxxxxxxxxx xxxxxxxxx xxxx anglickou x xxxxxxxxxxxx xxxxx xxxx xxxxxxxxxxx xxxxxxxx verze.
Tento Xxxxxx xxxx xxxxxx xx 1. xxxxx 2017
XXXXXX XXXXXXXXXX XXXXX X XXXXX DOPINGU XXX XXX 2017
SVĚTOVÝ XXXXXXXXXXXXX XXXXX
Xxxxxx xx 1. xxxxx 2017
Xxxxx xxxxxx 4.2.2 Xxxxxxxxx xxxxxxxxxxxxxxx kodexu xxxxxxx Xxxxxxxx xxxxx budou xxxxxxxxxx xx "Xxxxxxxxxx xxxxx" kromě xxxxx xx xxxxxx X1, X2, X4.4, S4.5 x S6(a) a Xxxxxxxxxx xxxxx X1, X2 a X3.
XXXXX X METODY ZAKÁZANÉ XXXXX (XXX XXXXXXX A XXXX XXXXXX) |
XXXXXXXX XXXXX
X0. XXXXXXXXXXX XXXXX
Xxxxxxxxx xxxxxxxxxxxxxx xxxxxx látka, xxxxx xxxx xxxxxxxx v xxxxxxxxxxxxx xxxxxxx Xxxxxxx x xxxx aktuálně xxxxxxxxx pro xxxxxxx xxxxxxxxxxxx použití xxxxxxxxxx xxxxxxx xxxxxxxxxxxxx regulačním xxxxxx (xxxx. xxxxxx x xxxxxxxxxxxx xxxx xxxxxxxxx stadiu výzkumu xxxx po xxxxxxxx xxxxxxxxxx, xxxxxxxxxx drogy, xxxxx schválené xxxxx xxx xxxxxxxxxxx xxxxxxx), xx xxxxxxxx stále.
S1. XXXXXXXXXX XXXXX
Xxxxxxxxxx látky xxxx zakázány.
1. XXXXXXXXXX XXXXXXXXXX XXXXXXXX (AAS):
(a) Xxxxxxxx* XXX, xxxxxxxxxx:
1-xxxxxxxxxxxxx (5α-xxxxxxx-1-xx-3ß,17ß-xxxx);
1-xxxxxxxxxxxxx (5α-xxxxxxx-1-xx-3,17-xxxx);
xxxxxxxxx (estr-4-en-3ß, 17ß-xxxx);
xxxxxxxxxx;
xxxxxxx ([1,2]xxxxxxx[4',5':2,3]xxxxxx-4-xx-20-xx-17α-xx);
xxxxxxxxxxxxxxxxxxxxxxxxxxxxx (4-xxxxxx-17ß-xxxxxxx-17α-xxxxxxxxxxxxxx-1,4-xxxx-3-xx);
xxxxxxxxxxxxxxxxxxxxxxx (17α-xxxxxx-5α-xxxxxxx-2-xx-17ß-xx);
xxxxxxxxxxx;
xxxxxxxxxxxxx (19-xxxxxxxxx-4-xx-17α-xx);
xxxxxxxxxxxxxx;
xxxxxxxxxx;
xxxxxxxxx (17α-methyl[1,2,5]oxadiazolo[3',4':2,3]-5α-androstan-17ß-ol);
gestrinon;
4-hydroxytestosteron (4,17ß-xxxxxxxxxxxxxxxx-4-xx-3-xx);
xxxxxxxxxx;
xxxxxxxxx;
xxxxxxxxxx;
xxxxxxxxxx;
xxxxxxxxxxx (17ß-hydroxy-17α-methylandrosta-1,4-dien-3-on);
metenolon;
methandriol;
metasteron (17ß-xxxxxxx-2α,17α-xxxxxxxx-5α-xxxxxxxxx-3-xx);
xxxxxxxxxxxxxx (17ß-xxxxxxx-17α-xxxxxxxxxxx-4,9-xxxx-3-xx);
xxxxxx-1-xxxxxxxxxxx (17ß-hydroxy-17α-methyl-5α-androst-1-en-3-on);
methylnortestosteron (17ß-xxxxxxx-17α-xxxxxxxxxx-4-xx-3-xx);
xxxxxXxxxxxxxxxxx;
xxxxxxxxxx (xxxxxxxxxxxxxxx (17ß-xxxxxxx-17α-xxxxxxxxxxx-4,9,11-xxxxx-3-xx);
xxxxxxxxx;
xxxxxxxxxx;
xxxxxxxxxxxxxx;
xxxxxxxxxxxx;
xxxxxxxx;
xxxxxxxxxx;
xxxxxxxxxxx;
xxxxxxxxxx;
xxxxxxxxxxx (17ß-[(xxxxxxxxxxxxxxx-2-xx)xxx]-1’X-xxxxxxxx[3,4:2,3]-5α-xxxxxxxxxx);
xxxxxxxxx;
xxxxxxxxxx;
xxxxxxxxx;
1-xxxxxxxxxxx (17ß-xxxxxxx-5α-xxxxxxx-1-xx-3-xx);
xxxxxxxxxxxxxxxxxxx (17-xxxxxxx-18α-xxxx-19-xxx-17α-xxxxxx-4,9,11-xxxxx-3-xx);
xxxxxxxxx (17ß-hydroxyestr-4,9,11-trien-3-on);
a xxxxx xxxxx x xxxxxxxx xxxxxxxxx xxxxxxxxxx xxxx xxxxxxxxx biologickými xxxxxx.
x. Endogenní** XXX, xxxxx xxxx xxxxxx xxxxxxxx:
Xxxxxxxxxxxxx (androst-5-en-3ß,17ß-diol);
androstendion (xxxxxxx-4-xx-3,17-xxxx);
xxxxxxxx;
xxxxxxx (xxxxxxxx-1,4-xxxx-3,17-xxxx);
xxxxxxxxxxxxxxxxxx (17ß-xxxxxxx-5α-xxxxxxxxx-3xx);
xxxxxxxxx (19-xxxxxxxxxxxxxx);
19-xxxxxxxxxxxxxxxx (xxxx-4-xx-3,17-xxxx);
19-xxxxxxxxxxxxxxxx (xxxx-4-xx-3,17-xxxx);
xxxxxxxxx (xxxxxxxxxxxxxxxxxxxxx, XXXX, 3ß-xxxxxxxxxxxxxx-5-xx-17-xx);
xxxxxxxxxxx;
x jejich xxxxxxxxxx x xxxxxxx, xxx xx s xxxxxxxx xxxxx xx xx:
5α-xxxxxxxxx-3α,17α-xxxx;
5α-xxxxxxxxx-3α,17ß-xxxx;
5α-xxxxxxxxx-3ß,17α-xxxx;
5α-xxxxxxxxx-3ß,17ß-xxxx;
5ß-xxxxxxxxx-3α,17ß-xxxx;
5α-xxxxxxx-2-xx-17-xx;
xxxxxxx-4-xx-3α,17α-xxxx;
xxxxxxx-4-xx-3α,17ß-xxxx;
xxxxxxx-4-xx-3ß,17α-xxxx;
xxxxxxx-5-xx-3α,17α-xxxx;
xxxxxxx-5-xx-3α,17ß-xxxx;
xxxxxxx-5-xx-3ß,17α-xxxx;
4-xxxxxxxxxxxxx (androst-4-en-3ß,17ß-diol);
5-androstendion (xxxxxxx-5-xx-3,17-xxxx);
xxxxxxxxxxx;
xxx-xxxxxxxxxxxxxxxxxx;
xxxxxxxxxxxxxx;
xxxxxxxxxxxxxx;
3ß-xxxxxxx-5α-xxxxxxxxx-17-xx;
7α-xxxxxxx-XXXX;
7ß-xxxxxxx-XXXX;
7-xxxx-XXXX;
19-xxxxxxxxxxxxxx;
19-xxxxxxxxxxxxxxxxx.
2. Xxxxxxx anabolické xxxxx, xxxxxxxxxx:
Xxxxxxxxxxx; selektivní xxxxxxxxxx xxxxxxxxxxxxx xxxxxxxxx (XXXX, xxxx. xxxxxxx a xxxxxxx); xxxxxxx; xxxxxxx x zilpaterol, xxx xx s omezením xxxxx xx xx.
Xxx xxxxx skupiny xxxx xxxxx: * "exogenní" xx xxxxxxxx x xxxxx, xxxxxx tělo normálně xxxxxxxxx neprodukuje. ** "endogenní " se xxxxxxxx x xxxxx, xxxxxx xxxx xxxxxxxx xxxxxxxxx xxxxxxxxx. |
X2. XXXXXXXXX HORMONY, XXXXXXX FAKTORY, XXXXXXXX XXXXX X XXXXXXXX
Xxxxxxxxxxx xxxxx a xxxxx xxxxx x xxxxxxxx xxxxxxxxx xxxxxxxxxx xxxx xxxxxxxxx xxxxxxxxxxxx xxxxxx xxxx xxxxxxxx:
1. Xxxxxxxx xxxxxxxxxxxxxxxxx receptoru:
1.1 Xxxxx xxxxxxxxxxx erytropoesu (XXX) xxxxxx xxxx.
xxxxxxxxxxxx (xXXX);
xxxxxxxxxxxxx (XXX);
XXX-Xx;
XXX-xxxxxxxxxxx peptidů (EMP), xxxx. XXXX 530 x peginesatid;
inhibitory XXXX, xxxx. K-11706;
methoxypolyethylenglykol-epoetin xxxx (XXXX);
xxxxxxxxxx xxxxxxxxxxxxxxxx xxxxxxxxx xxxxxxx xxxx (XXX-xxxx), xxxx. xxxxxxxxxxx, xxxxxxxxxxxx;
1.2 Xxxxxxxx neerytropoetického XXX xxxxxxxxx, např.
ARA-290;
asialo XXX;
xxxxxxxxxxxxx XXX;
2. Xxxxxxxxxxxxx xxxxxxx xxxxxxxxxxxxxx xxxxxxx (XXX), xxxx. kobalt, xxxxxxxxxx x xxxxxxxxxx (XX-4592); x xxxxxxxxxx XXX, xxxx. argon a xxxxx.
3. Choriogonadotropin (XX) x luteinizační xxxxxx (XX) x xxxxxx xxxxxxxxxx xxxxxxx, xxxx. xxxxxxxxx, xxxxxxxxxxx a xxxxxxxxxxx, x xxxx.
4. Xxxxxxxxxxxxxx x xxxxxx xxxxxxxxxx xxxxxxx, xxxx. xxxxxxxxxxxx.
5. Růstový xxxxxx (XX) x jeho xxxxxxxxxx xxxxxxx včetně: xxxxxxx xxxxxxxxxxxx růstový xxxxxx (GHRH) x xxxx analogů, např. XXX-1295, xxxxxxxxxxx x xxxxxxxxxxxx; sekretagogů růstového xxxxxxx (XXX), xxxx. xxxxxxxx a mimetik xxxxxxxx, např. xxxxxxxxxxx x xxxxxxxxxxx; uvolňujících xxxxxxx růstového xxxxxxx (XXXX), xxxx. xxxxxxxxxxxxx, XXXX-6, hexarelinu x xxxxxxxxxxxx (XXXX- 2).
Kromě xxxx jsou zakázány xxxxxxxxxxx xxxxxxx faktory:
Fibroblastové xxxxxxx faktory (FGFs); xxxxxxxxxxxx xxxxxxx faktor (XXX); xxxxxxxx podobný xxxxxxx xxxxxx-1 (XXX-1) x xxxx xxxxxxx; xxxxxxxxxx xxxxxxx faktory (XXX); růstový xxxxxx xxxxxxxx x xxxxxxxx xxxxxxxx (PDGF); xxxxxxxxxx-xxxxxxxxxxxx xxxxxxx xxxxxx (XXXX), xxxxxx xxxx xxxxxxxxx xxxx xxxxxxx xxxxxxx xxxxxxxxxxx xxxxxxx xxxx xxxxxxxxx xxxxxxxx svalů, xxxxx x xxxxxx, xxxxxx zásobení, využití xxxxxxx, xxxxxxxxxxxxx xxxxxxxx xxxx xxxxxxxxxxx typy xxxxxxxxx xxxxxx.
X3. BETA2- XXXXXXXX
Xxxxxxx xxxxxxxxxx i xxxxxxxxxxxx xxxx2- xxxxxxxx, xxxxxx xxxxx xxxxxxxxx xxxxxxx, xxxx zakázáni.
Zahrnují (xxx ne x xxxxxxxx xxxxx xx xx):
Xxxxxxxxx; formoterol; xxxxxxxxx; xxxxxxxxxxx; xxxxxxxxxx; xxxxxxxxxx; xxxxxxxxxx; salbutamol; salmeterol; xxxxxxxxxx; xxxxxxxxxx.
Xxxxxxxx xxxx:
- xxxxxxxxx xxxxxxxxxx: xxxxxxxxx 1600 xxxxxxxxxx xx 24 xxxxx, nepřekročit 800 xxxxxxxxxx xx xxxxxxx 12 xxxxx;
- xxxxxxxxx xxxxxxxxxx: xxxxxxxxx xxxxxx xxxxx 54 xxxxxxxxxx xx 24 xxxxx;
- xxxxxxxxx xxxxxxxxxx: xxxxxxxxx 200 xxxxxxxxxx xx 24 xxxxx.
Xxxxxxxxxx xxxxxxxxxxx x moči x xxxxxxxxxxx xxxxx xxx 1000 xx/xx x xxxxxxxxxx formoterolu x xxxx x xxxxxxxxxxx xxxxx xxx 40 ng/ml xxxxxx xxxxxxxxxx xx zamýšlené xxxxxxxxxxxx použití, ale xxxx xxxxxxxxxx xx xxxxxxxxx laboratorní nález, xxxxx xxxxxxxxx xxxxxxxxx xxxxxxxxxxxxx xxxxxxxxxxxxxxxxx xxxxxx, xx abnormální výsledek xxx xxxxxxxx užíváním xxxxxxxxxxxx dávky (x xxxxxxxx) xxxxx, xxx xxxx xxxxxxx xxxxxxxxx xxxxx.
X4. XXXXXXXXX X XXXXXXXXXXX XXXXXXXXXX
Xxxxxxxx jsou xxxxxxxxxxx xxxxxxxxx a xxxxxxxxxxx xxxxxxxxxx:
1. Inhibitory xxxxxxxx, zahrnující:
Aminoglutethimid;
anastrozol;
androsta-1,4,6-trien-3-17-dion (androstatriendion);
androsta-3,5-dien-7-17-dion (xxxxxxxxx);
4-xxxxxxxxx-3,6,17-xxxxx (6-xxx);
xxxxxxxxx;
xxxxxxxxx;
xxxxxxxx;
xxxxxxxxxxx,
xxx ne x xxxxxxxx xxxxx xx xx.
2. Selektivní xxxxxxxxxx xxxxxxxxxxxxx xxxxxxxxx (XXXX), xxxxxxxxxx:
Xxxxxxxxx;
xxxxxxxxx;
xxxxxxxxx, xxx xx x xxxxxxxx xxxxx xx xx.
3. Xxxxxxx xxxxxxxxxxxxxx xxxxx zahrnující:
Cyklofenil; fulvestrant x xxxxxxxx, xxx xx s omezením xxxxx na xx.
4. Xxxxx xxxxxxxxxxxx xxxxxx(x) xxxxxxxxxx xxxxxx xxxxxxxxxx xxxxxxxxxx, xxx xx
x xxxxxxxx xxxxx na xx.
5. Xxxxxxxxxxx xxxxxxxxxx:
5.1 Xxxxxxxxxx XXX-xxxxxxxxxx xxxxxxxxxxxxx (XXXX), např. XXXXX; x Xxxxxxxx Receptoru xxxxx xxxxxxxxxxxx xxxxxxxxxxxxxx xxxxxxxxxxxxx (XXXXδ), xxxx. XX 1516;
5.2 Xxxxxxxx x xxxxxxxx xxxxxxxx;
5.3 Xxxxxxxxx;
5.4 Trimetazidin.
S5. XXXXXXXXX X XXXXXXXXX LÁTKY
Následující xxxxxxxxx x xxxxxxxxx xxxxx jsou zakázané, xxxxxx xxxx další xxxxx x xxxxxxxx xxxxxxxxx xxxxxxxxxx x xxxxxxxxx xxxxxxxxxxxx účinky.
Zahrnují:
-
Desmopressin, xxxxxxxxxxxxxxx (např. xxxxxxxx, xxxxxxxxxx podání albuminu, xxxxxxxx, xxxxxxxxxxxxxxxxxx x xxxxxxxxx), xxxxxxxxxx, xxx xx x omezením xxxxx xx xx.
-
Xxxxxxxxxxxx, xxxxxxxx, bumetanid, xxxxxxxxx, xxxxxxxxxxxx, xxxxxxxxx, xxxxxxxx, xxxxxxxx xxxxxxxxxx, xxxxxxxxx, xxxxxxxxxxxxx, xxxxxxxx (xxxx. xxxxxxxxxxxxxxxxxx, hydrochlorothiazid, xxxxxxxxxxxxx), xxxxxxxxxx a vaptany (xxxx. xxxxxxxxx), xxx xx s omezením xxxxx xx ně.
S xxxxxxxx:
-
xxxxxxxxxxxx, pamabromu x xxxxxx xxxxxx inhibitorů xxxxxxxxxxxxxx (xxxx. xxxxxxxxxxx x brinzolamidu)
-
Lokálního podání xxxxxxxxxxxx xxx xxxxx xxxxxxxxx
Xxxxx xxxxxxxxxxx xxxxxxxx xxxxx xx xxxxxxxxxx xxxxxxxx limitem (xx. xxxxxxxxxx, xxxxxxxxxx, xxxxx, xxxxxxx, xxxxxxxxxxxx x xxxxxxxxxxxxx) ve Xxxxxx Xxxxxxxxx xxxxxxxx nebo
případně Xxx Xxxxxxx xx xxxxxxx x xxxxxxxxxx xxxx jinou maskovací xxxxxx, bude považováno xx Xxxxxxxxx xxxxxxxxxxx xxxxx, xxxxx Sportovec xxxx xxxxxxxxxx Xxxxxxxxxxxxx xxxxxxx (XX) na xxxx xxxxx xxxxx x xx, která xxx xxxx udělena xx xxxxxxxxxx xxxx xxxxx maskovací xxxxx.
XXXXXXXX XXXXXX
X1. XXXXXXXXXX S XXXX X XXXXXXXX XXXXXXXXXXXX
Xxxxxxxx je následující:
1. Xxxxxx nebo xxxxxxxxxxxxx xxxxxxxxxxx množství autologní, xxxxxxxx (xxxxxxxxx) xxxx xxxxxxxxxxx krve xxxx xxxxxxxxx krvinek a xxx xxxxxxxxx xxxxxxxx xxxxxxxxxxx původu xx xxxxxxxxx xxxxxxx.
2. Xxxxx xxxxxxxxx xxxxxxxx, přenosu xxxx dodávky xxxxxxx.
Xxxxxxxxxx:
xxxxxxxxxxxx xxxxxxxxxxxxx xxxxxxxx (xxxx. xxxxxx xxxxxxxx xxxxxxxx xx hemoglobinu x xxxxxxxxxxxxxxxxxx xxxxxxxxxxx), xxxxxxxxxxxxxxxxxxx x xxxxxxxxxxx (XXX13), xxx xx x xxxxxxxx pouze xx xx. Xxxxxxxxx suplementace xxxxxxxx xxxxxxxx není.
3. Xxxxxxxxx xxxxx intravaskulární xxxxxxxxxx x krví xxxx x xxxxxxxx xxxxxxxxxxxx xxxxxxxxxxx nebo xxxxxxxxxx způsoby.
M2. CHEMICKÁ X FYZIKÁLNÍ XXXXXXXXXX
Xxxxxxxx xx xxxxxxxxxxx:
1. Xxxxxxxxx, xxxx Pokus x Xxxxxx, xx xxxxxx xxxxxxx xxxxxxxxx a xxxxxxxx Vzorků odebraných xxx Xxxxxxxxx kontrole. Xx xxxxxxxx xxxxxx x/xxxx xxxxxx (např. xxxxxxxxxx) xxxx, xxx xx s xxxxxxxx xxxxx xx xx.
2. Xxxxxxxxxx infuze x/xxxx xxxxxxx xxxx xxx 50 xx za 6 xxxxx kromě xxxxxx xxxxxxxxx přijatých x xxxxxxx xxxxxxxxxxxx xxxxxxx, xxxxxxxxxxxxx xxxxxxx xxxx xxxxxxxxxx vyšetřovacích xxxxx.
X3. XXXXXX DOPING
Z xxxxxx xxxxxxxxxx xx xxxxxxx sportovního výkonu xx xxxxxxxx xxxxxxxxxxx:
1. Xxxxxxxx xxxxxxxx nukleových xxxxxxx xxxx jejich xxxxxxx;
2. Použití xxxxxxxxxx xxxx xxxxxxxxx xxxxxxxxxxxxxx xxxxx;
XXXXX X METODY XXXXXXXX XXX XXXXXXX |
Xxxxx xxxxxxxxx X0 xx X5 x X1 xx M3 xxxxxxxxx xxxx
xxxx Při Soutěži xxxxxxxx x xxxxxxxxxxx xxxxxxx:
XXXXXXXX XXXXX
X6. XXXXXXXXXXX
Xxxxxxx xxxxxxxxxxx xxxxxx xxxxx xxxxxx případných optických xxxxxxx, xxxx. x- x X-, xxxx xxxxxxxx.
Xxxxxxxxxxx zahrnují:
(a) Xxxxxxxxxxxx xxxxxxxxxxx:
Xxxxxxxxx,
xxxxxxxxxx,
xxxxxxxxx,
xxxxxxxxxxx,
xxxxxxxxxx,
xxxxxxxxxx,
xxxxxxxxxxxxxxx,
xxxxxxxxx,
xxxxxxxxxxxxx,
xxxxxxxxx,
xxxxxxxxxxx,
xxxxxxxx,
xxxxxxxxxxx,
xxxxxxxxx,
xxxxxxxxxxxx /4-xxxxxxxxxxxxxx (karfedon)/,
furfenorex,
klobenzorex,
kokain,
kropropamid,
krotetamid,
lisdexamfetamin,
mefenorex,
mefentermin,
metamfetamin (x-),
xxxxxxxx,
xxxxxxxxx,
xxxxxxxxxxxxxx,
x-xxxxxxxxxxxxxx,
xxxxxxxxxx,
xxxxxxxxx.
Xxxxxxxxxxxx, xxxxx xxxx xxxxxxxx xxxxxxx x xxxxx xxxxxxxx, xx Xxxxxxxxxxx látkou.
(b) Specifická xxxxxxxxxxx.
Xxxxxxxx (ale ne x xxxxxxxx xxxxx xx ně):
Adrenalin (xxxxxxxxx)****,
xxxxxxxxxxx,
xxxxxxxxxxxxxxxxx,
xxxxxxx***,
xxxxxxxx,
xxxxxxxxxxxxx,
xxxxxxxxx,
xxxxxxxxxxx,
xxxxxxxxxxx,
xxxxxxxxxxx x xxxx deriváty,
fenkamfamin,
fenmetrazin,
fenprometamin,
heptaminol,
hydroxyamfetamin (xxxxxxxxxxxxxxxxxxxx),
xxxxxxxxxxxx,
xxxxx**,
xxxxxxx x xxxx xxxxxxx (xxxx. mefedron, xxxxxxxxx x alfa-pyrolidinovalerofenon),
levmetamfetamin,
meklofenoxát,
metylefedrin***,
metylendioxymetamfetamin,
metylfenidát,
4-metylhexan-2-amin (xxxxxxxxxxxxxx),
xxxxxxxxx,
xxxxxxxxxxx,
xxxxxxxxx,
xxxxxxxxx (xxxxxxxxxxxxx),
xxxxxxx,
xxxxxxxxxxx,
xxxxxxxxxxxxxx,
xxxxxxxxxxxxx*****,
xxxxxxxxx,
xxxxxxxxxx,
xxxxxxxxx,
xxxxxxxxxxxx (xxxxxxxxxxxxxxxxxxxxx),
xxxxxxxxxxxxx
x xxxxx xxxxx s xxxxxxxx xxxxxxxxx xxxxxxxxxx xxxx xxxxxxxxx xxxxxxxxxxxx xxxxxx.
X výjimkou:
-
klonidinu
-
derivátů imidazolu x případě xxxxxx xxxxxxxx/xxxxxx xxxxxxx a xxxxxxxxxxx zahrnutých xx Xxxxxxxxxxxxxx programu pro xxx 2017*.
* Xxxxxxxxx, xxxxxxxxxx, xxxxxxxxxxxxxxxxx, xxxxxx, xxxxxxx, xxxxxxxxx x xxxxxxxx: Xxxx xxxxx xxxx xxxxxxxx do Xxxxxxxxxxxxxx xxxxxxxx 2017 x xxxxxx xxxxxxxxxx xx Xxxxxxxx látky.
** Xxxxx: xx xxxxxxxx xxxxx při xxxxxxxxxxx xxxxx xxx 5 xxxxxxxxxx x 1 xx xxxx.
*** Xxxxxxx x xxxxxxxxxxxxx: xxxx xxxxxxxx xxx xxxxxxxxxxx xxxxx xxx 10 xxxxxxxxxx x 1 xx xxxx.
**** Xxxxxxxxx (xxxxxxxxx): xxxx xxxxxxx xxx xxxxxxxx xxxxxx, xxxx. nosní, xxxx xxxxxxxx xxxx xxxx xxxxxx xxxxxxxx x xxxxxxxxx xxxxxxxxxx.
***** Pseudoefedrin: xx xxxxxxx, xxxxx xxxx xxxxxxxxxxx x xxxx je vyšší xxx 150 xxxxxxxxxx xx xxxxxxxx.
X7. XXXXXXXXX
Xxxxxxxx xx xxxxxxxxxxx:
Xxxxxxxxxxx,
xxxxxxxxxxxxx,
xxxxxxxxx(xxxxxx),
xxxxxxxx x xxxx xxxxxxxx,
xxxxxxxxxxx,
xxxxxxx,
xxxxxx,
xxxxxxxxxx,
xxxxxxxx,
xxxxxxxxx,
xxxxxxxxxx,
xxxxxxx.
X8. XXXXXXXXXXX
Xxxxxxxx xx xxxxxxxxxxx:
-
Xxxxxxxx (xxxx. xxxxx, konopí x xxxxxxxxx) xxxx xxxxxxxxxx xxxxx9-xxxxxxxxxxxxxxxxxxx (XXX).
-
Xxxxxxxxxxxxxx, např. "Xxxxx", JWH018, JWH073 x HU-210.
S9. GLUKOKORTIKOIDY
Všechny xxxxxxxxxxxxxxx xxxxxxxx orálně, xxxxxxxx, xxxxxxxxxx nebo xxxxxxxxxxxxx xxxxxxxx xxxx xxxxxxxx.
XXXXX XXXXXXXX V URČITÝCH XXXXXXXX |
X1. XXXXXXX
Xxxxxxx (xxxxxx) xx xxxxxxxx xxxxx Xxx Xxxxxxx x xxxxxxxxxxxxx xxxxxxxx. Xxxxxxx xx xxxx xxxxxxxx xxxxxxxx zkouškou x/xxxx xxxxxxxx xxxx. Prahová xxxxxxx xxx porušení xxxxxxxxxxx xxxxxxxx xx xxxxxxxxxxxx xxxxxxxxxxx xxxxxxxx x krvi 0,10 x/x.
-
Xxxxxxxxxxxx sport (FIA)
-
Lukostřelba (XX)
-
Xxxxxxx xxxxxx x xxxxxxxxxxxx (FAI)
-
Vodní motorismus (XXX)
X2. XXXX-XXXXXXXXX
Xxxx-xxxxxxxxx jsou xxxxxxxx xxxxx x xxxxxxxxxxxxx xxxxxxxx Při Xxxxxxx, x xxx xx xx xxxxxxxx x Xxxx soutěž.
-
Automobilový xxxxx (FIA)
-
Billiard (xxxxxxx xxxxxxxxxx) (XXXX)
-
Xxxx (XXX)
-
Xxxxxxxxxxx (XX)*
-
Xxxxxxxx (XXX) - xxxxx na xxxxxx x xxxxxxxxxxx xxxxxxxx-xxxxx x U-rampa, a xxxxxxxxx X-xxxxx x "xxx air"
-
Podvodní xxxxxx (xxxxxxxxx potápění) (XXXX) x xxxxxxxxxxxx xxxxxxxxxx xxxx s ploutvemi xxxx bez xxxxxxx, xxxxxxxxx apnoe s xxxxxxxxx xxxx bez xxxxxxx, xxxx immersion, xxxx xxxx, xxxxxxxxxxxx, xxxxxxxx xxxxx, xxxxxxx xxxxxxxx xx xxxx x xxxxxxxxxx xxxx.
-
Xxxxxxx (XXXX, XXX)*
-
Xxxxx (XXX)
* Xxxxxxxx také Xxxx xxxxxx
Xxxx-xxxxxxxxx zahrnují xxxxxxxxxxx xxxxx:
Xxxxxxxxxx,
xxxxxxxxxx,
xxxxxxxx,
xxxxxxxxx,
xxxxxxxxxx,
xxxxxxx,
xxxxxxxxxx,
xxxxxxx,
xxxxxxxxx,
xxxxxxxxxx,
xxxxxxxxx,
xxxxxxxxxxx,
xxxxxxxxxxxx,
xxxxxxxxxx,
xxxxxxx,
xxxxxxxxxx,
xxxxxxxx,
xxxxxxxxxxx,
xxxxxxx,
xxxxxxx,
xxx xx s xxxxxxxx xxxxx xx xx.
Xxxxxxxxx
Xxxxxx xxxxxxx x. 80/2017 Sb. x. x. xxxxx xxxxxxxxx xxxx 4.1.2018.
Xxxxxx předpis x. 80/2017 Xx. x. x. xxx xxxxxx právním xxxxxxxxx č. 36/2019 Sb. m. s. x účinností xx 26.7.2019.
Znění xxxxxxxxxxxx xxxxxxxx xxxxx jiných xxxxxxxx xxxxxxxx x xxxxxxxx xxxx aktualizováno, xxxxx se xxxx xxxxxx xxxxxxxxx xxxxx xxxxx uvedeného xxxxxxxx xxxxxxxx.
1) Xxxxxxxxxxx úmluva xxxxx dopingu xx xxxxxx, xxxxxxx xxx 19. xxxxx 2005 x Xxxxxx, xxxx xxxxxxxxx x xxxxxxxxx xxxxx x x xxxxxxxxx do českého xxxxxx xxx č. 58/2007 Sb. m. s.
Xxxx xxxxx xxxxxxxx Xxxxxx xx českého xxxxxx xxxx xxxxxxxxx xxx č. 46/2008 Sb. m. s.